InnovationWe are Asia’s only super-specialized distribution and commercialization platform for Oncology and Immunology assets. Our core value proposition  is to provide end-to-end solutions – drugs, drug delivery devices and companion diagnostics in these disease areas. Our business model encompasses Global access / early access programs, Named Patient programs and securing product registrations for exclusive commercial distribution in South Asia. We intend to be the partner of choice for oncology and immunology companies having limited to no commercial footprint in South Asia.